[go: up one dir, main page]

DK615889D0 - Peptidderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat - Google Patents

Peptidderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat

Info

Publication number
DK615889D0
DK615889D0 DK615889A DK615889A DK615889D0 DK 615889 D0 DK615889 D0 DK 615889D0 DK 615889 A DK615889 A DK 615889A DK 615889 A DK615889 A DK 615889A DK 615889 D0 DK615889 D0 DK 615889D0
Authority
DK
Denmark
Prior art keywords
derivative
pct
preparing
procedure
pharmaceutical preparation
Prior art date
Application number
DK615889A
Other languages
English (en)
Other versions
DK615889A (da
DK167813B1 (da
Inventor
Fred Widmer
Kailash Kumar Gauri
Original Assignee
Carlsberg Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlsberg Biotechnology Ltd filed Critical Carlsberg Biotechnology Ltd
Publication of DK615889D0 publication Critical patent/DK615889D0/da
Priority to DK615889A priority Critical patent/DK167813B1/da
Priority to AU68989/91A priority patent/AU636427C/en
Priority to FI922620A priority patent/FI922620A0/fi
Priority to CA002069449A priority patent/CA2069449A1/en
Priority to DE69030100T priority patent/DE69030100D1/de
Priority to AT91900187T priority patent/ATE149517T1/de
Priority to KR1019920701341A priority patent/KR927003631A/ko
Priority to JP3500941A priority patent/JPH05504336A/ja
Priority to EP91900187A priority patent/EP0504207B1/en
Priority to US07/859,714 priority patent/US5411942A/en
Priority to PCT/DK1990/000322 priority patent/WO1991009053A1/en
Priority to HU921883A priority patent/HUT61322A/hu
Publication of DK615889A publication Critical patent/DK615889A/da
Priority to NO92922229A priority patent/NO922229L/no
Priority to LVP-92-320A priority patent/LV10107B/en
Application granted granted Critical
Publication of DK167813B1 publication Critical patent/DK167813B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK615889A 1989-12-07 1989-12-07 Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat DK167813B1 (da)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DK615889A DK167813B1 (da) 1989-12-07 1989-12-07 Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
KR1019920701341A KR927003631A (ko) 1989-12-07 1990-12-07 펩티드 유도체, 그 제조방법, 이를 함유한 제제 및 녹내장의 치료방법
EP91900187A EP0504207B1 (en) 1989-12-07 1990-12-07 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it
CA002069449A CA2069449A1 (en) 1989-12-07 1990-12-07 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma
DE69030100T DE69030100D1 (de) 1989-12-07 1990-12-07 Peptidderivat, verfahren zu dessen herstellung, sowie dieses enthaltende pharmazeutische zusammensetzung
AT91900187T ATE149517T1 (de) 1989-12-07 1990-12-07 Peptidderivat, verfahren zu dessen herstellung, sowie dieses enthaltende pharmazeutische zusammensetzung
AU68989/91A AU636427C (en) 1989-12-07 1990-12-07 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma
JP3500941A JPH05504336A (ja) 1989-12-07 1990-12-07 ペプチド誘導体，その製法，これを含む医薬品及び緑内障の治療法
FI922620A FI922620A0 (fi) 1989-12-07 1990-12-07 Peptidderivat, foerfarande foer dess framstaellning, ett farmaceutisk preparat innehaollande detta och foerfarande foer behandling av glaukoma.
US07/859,714 US5411942A (en) 1989-12-07 1990-12-07 Peptide derivative, pharmaceutical preparation containing it and method for treatment of glaucoma
PCT/DK1990/000322 WO1991009053A1 (en) 1989-12-07 1990-12-07 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma
HU921883A HUT61322A (en) 1989-12-07 1990-12-07 Process for producing peptide derivatives suitable for treating glaucoma and pharmaceutical compositions comprising same as active ingredient
NO92922229A NO922229L (no) 1989-12-07 1992-06-05 Peptid derivativ, fremgangsmaate til fremstilling av dissefarmasoeytiske preparater som inneholder disse og fremgangsmaate for behandling av glaucoma
LVP-92-320A LV10107B (en) 1989-12-07 1992-12-17 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucome

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK615889A DK167813B1 (da) 1989-12-07 1989-12-07 Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
DK615889 1989-12-07

Publications (3)

Publication Number Publication Date
DK615889D0 true DK615889D0 (da) 1989-12-07
DK615889A DK615889A (da) 1991-06-08
DK167813B1 DK167813B1 (da) 1993-12-20

Family

ID=8147734

Family Applications (1)

Application Number Title Priority Date Filing Date
DK615889A DK167813B1 (da) 1989-12-07 1989-12-07 Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat

Country Status (12)

Country Link
US (1) US5411942A (da)
EP (1) EP0504207B1 (da)
JP (1) JPH05504336A (da)
KR (1) KR927003631A (da)
AT (1) ATE149517T1 (da)
CA (1) CA2069449A1 (da)
DE (1) DE69030100D1 (da)
DK (1) DK167813B1 (da)
FI (1) FI922620A0 (da)
HU (1) HUT61322A (da)
LV (1) LV10107B (da)
WO (1) WO1991009053A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
DK53291D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Smaa peptider og peptidrelaterede stoffer samt farmaceutiske praeparater indeholdende saadanne forbindelser
DK53191D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Organosvovlforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
US5561107A (en) * 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5773413A (en) * 1993-06-04 1998-06-30 Demeter Biotechnologies, Ltd. Method of combating mammalian neoplasias, and lytic peptides therefor
US5968904A (en) * 1993-06-04 1999-10-19 Demegen, Inc. Modified arginine containing lytic peptides and method of making the same by glyoxylation
PT885242E (pt) * 1995-06-07 2008-06-18 Glaxo Group Ltd Péptidos e compostos que se ligam a um receptor de trombopoietina
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
US8283315B2 (en) * 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
EA010759B1 (ru) 2002-09-18 2008-10-30 Орто-Макнейл Фармасьютикал, Инк. Способы увеличения продукции тромбоцитов и гематопоэтических стволовых клеток
US20040171554A1 (en) * 2003-02-07 2004-09-02 Genentech, Inc. Compositions and methods for enhancing apoptosis
US8076060B2 (en) * 2003-08-04 2011-12-13 Emil William Chynn Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
EA009286B1 (ru) * 2003-08-28 2007-12-28 Орто-Макнейл Фармасьютикал, Инк. Пептиды и соединения, которые связываются с рецептором
US7723295B2 (en) * 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
AU2005228950B2 (en) * 2004-03-23 2012-02-02 Genentech, Inc. Azabicyclo-octane inhibitors of IAP
EP1735307B1 (en) * 2004-04-07 2012-08-29 Novartis AG Inhibitors of iap
RS53734B1 (en) * 2004-07-02 2015-06-30 Genentech Inc. IAP INHIBITORS
US20060210542A1 (en) * 2004-08-16 2006-09-21 Yurkow Edward J Use of TPO mimetic compounds and pharmaceutical compositions in the treatment of anemia
KR20120127754A (ko) 2004-12-20 2012-11-23 제넨테크, 인크. Ｉａｐ의 피롤리딘 억제제
CN101374829A (zh) * 2005-12-19 2009-02-25 健泰科生物技术公司 Iap的抑制剂
PE20110217A1 (es) 2006-08-02 2011-04-01 Novartis Ag DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS
CN101605786A (zh) * 2006-12-19 2009-12-16 健泰科生物技术公司 细胞凋亡抑制剂的咪唑并吡啶抑制剂
BRPI0810471A2 (pt) * 2007-04-16 2014-11-11 Momenta Pharmaceuticals Inc Produtos de glicoproteína definidos e métodos relacionados
CL2008001234A1 (es) * 2007-04-30 2008-09-22 Genentech Inc Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer.
DK2240506T3 (da) * 2008-01-11 2013-04-08 Genentech Inc IAP inhibitorer
NZ590550A (en) 2008-08-02 2013-05-31 Genentech Inc Inhibitors of Apoptosis (IAP) for treating cancer
CA2730357A1 (en) * 2008-08-16 2010-02-25 Genetech, Inc. Azaindole inhibitors of iap
RU2402316C2 (ru) * 2009-01-11 2010-10-27 Пшеничников Виталий Георгиевич Фармацевтическая антиглаукомная композиция
ES2602108T3 (es) 2010-04-07 2017-02-17 Momenta Pharmaceuticals, Inc. Método para cuantificar glicoformas que contienen alta manosa
WO2012125553A2 (en) 2011-03-12 2012-09-20 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing n-glycans in glycoprotein products
US9695244B2 (en) 2012-06-01 2017-07-04 Momenta Pharmaceuticals, Inc. Methods related to denosumab
WO2014149067A1 (en) 2013-03-15 2014-09-25 Momenta Pharmaceuticals, Inc. Methods related to ctla4-fc fusion proteins
ES2708759T3 (es) 2013-05-13 2019-04-11 Momenta Pharmaceuticals Inc Procedimientos para el tratamiento de la neurodegeneración
US20160257754A1 (en) 2013-10-16 2016-09-08 Momenta Pharmaceuticals Inc. Sialylated glycoproteins
JP2023518853A (ja) * 2020-03-25 2023-05-08 アウフバウ・メディカル・イノベイションズ・リミテッド 緑内障のためのプロセスおよび薬剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457489A (en) * 1981-07-13 1984-07-03 Gilmore Samuel E Subsea fluid conduit connections for remote controlled valves
DE3360065D1 (en) * 1982-03-08 1985-03-28 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
US4559340A (en) * 1983-11-25 1985-12-17 Schering Corporation Antihypertensive agents
US4634698A (en) * 1984-09-24 1987-01-06 Schering Corporation Antiglaucoma agents
US4918008A (en) * 1985-01-18 1990-04-17 Gauri Kailash Kumar Process for the preparation of protein hydrolysate and medicaments containing these hydrolysates
IL86386A0 (en) * 1987-05-21 1988-11-15 Merrell Dow Pharma Novel anf derivatives
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
GB8728560D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
JPH05504336A (ja) 1993-07-08
LV10107B (en) 1995-02-20
FI922620L (fi) 1992-06-05
FI922620A7 (fi) 1992-06-05
HUT61322A (en) 1992-12-28
DK615889A (da) 1991-06-08
US5411942A (en) 1995-05-02
KR927003631A (ko) 1992-12-18
DE69030100D1 (de) 1997-04-10
CA2069449A1 (en) 1991-06-08
AU636427B2 (en) 1993-04-29
AU6898991A (en) 1991-07-18
HU9201883D0 (en) 1992-09-28
EP0504207B1 (en) 1997-03-05
EP0504207A1 (en) 1992-09-23
ATE149517T1 (de) 1997-03-15
LV10107A (lv) 1994-05-10
WO1991009053A1 (en) 1991-06-27
DK167813B1 (da) 1993-12-20
FI922620A0 (fi) 1992-06-05

Similar Documents

Publication Publication Date Title
DK615889D0 (da) Peptidderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
IL112112A0 (en) Peptide derivatives and pharmaceutical compositions containing them
DE3166150D1 (en) N-(vinblastinoyl-23) derivatives of amino acids and peptides and their preparation
DK0835262T3 (da) Fremgangsmåde til behandling af corticosteroidinduceret osteopenia
FI113644B (fi) Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi
NO20000231L (no) Dolastatin-15-derivater
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
NO306609B1 (no) I det vesentlige sfaerisk vateritt og fremgangsmåte for fremstilling derav
DK0589995T3 (da) Hidtil ukendte polypeptider og deres anvendelse
DE69420872D1 (de) Hgh enthaltende pharmazeutische zubereitungen
SE9604593D0 (sv) Antimicrobially active polypeptides
DE68918944D1 (de) Künstliche rezeptor-analoge.
DE3462692D1 (en) Pharmacologically active peptides
HUT61485A (en) Process for producing drug composition suitable for treating thrombocytopenia
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
NO922229L (no) Peptid derivativ, fremgangsmaate til fremstilling av dissefarmasoeytiske preparater som inneholder disse og fremgangsmaate for behandling av glaucoma
AU6393990A (en) Hiv related peptides
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
IT1243778B (it) Derivati salini dell'acido tauroursodesossicolico, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
MX9700199A (es) Composiciones de cadena invariante utiles para tratar enfermedades autoinmunes.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed